Literature DB >> 12411730

Different aetiology of familial low-grade and high-grade glioma? A nationwide cohort study of familial glioma.

Beatrice Malmer1, Roger Henriksson, Henrik Grönberg.   

Abstract

An increased risk for first-degree relatives (FDR) of glioma patients has previously been observed. The novel objective of this study was to investigate differences in familial risk among FDR of low-grade glioma (LGG) and high-grade glioma (HGG) cases, respectively. Two cohorts were constructed, one from 15,321 FDR of LGG cases and the other from 26,635 FDR of HGG cases calculating standardised incidence ratios (SIR). The risk for LGG among FDR of LGG cases was significantly increased, SIR 3.65 (95% CI 2.31-5.47). The risk was even higher in the cohort of siblings, SIR 7.00 (95% CI 3.35-12.87), and especially in the younger siblings (<40 years), SIR 9.01 (95% CI 4.31-16.57). When calculating the risk for HGG in the LGG cohort and the risk for HGG in the HGG cohort, there was a generally twofold increased risk, but no trends of increased risk in relatives of younger probands. Two different methods calculating familial risk displayed similar results. LGG families apparently have features manifesting a distinct pedigree pattern with sibpairs affected at a young age. These families could provide new insights into the aetiology of glioma. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12411730     DOI: 10.1159/000065528

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  8 in total

Review 1.  Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium.

Authors:  Melissa L Bondy; Michael E Scheurer; Beatrice Malmer; Jill S Barnholtz-Sloan; Faith G Davis; Dora Il'yasova; Carol Kruchko; Bridget J McCarthy; Preetha Rajaraman; Judith A Schwartzbaum; Siegal Sadetzki; Brigitte Schlehofer; Tarik Tihan; Joseph L Wiemels; Margaret Wrensch; Patricia A Buffler
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

2.  Familiality in brain tumors.

Authors:  Deborah T Blumenthal; Lisa A Cannon-Albright
Journal:  Neurology       Date:  2008-09-23       Impact factor: 9.910

Review 3.  Familial aggregation of glioma: a pooled analysis.

Authors:  Michael E Scheurer; Carol J Etzel; Mei Liu; Jill Barnholtz-Sloan; Fredrik Wiklund; Björn Tavelin; Margaret R Wrensch; Beatrice S Melin; Melissa L Bondy
Journal:  Am J Epidemiol       Date:  2010-09-21       Impact factor: 4.897

Review 4.  Inherited predisposition to glioma.

Authors:  Athanassios P Kyritsis; Melissa L Bondy; Jasti S Rao; Chrissa Sioka
Journal:  Neuro Oncol       Date:  2009-11-23       Impact factor: 12.300

Review 5.  The TERT rs2736100 polymorphism and cancer risk: a meta-analysis based on 25 case-control studies.

Authors:  Peng Zou; Aihua Gu; Guixiang Ji; Lin Zhao; Peng Zhao; Ailin Lu
Journal:  BMC Cancer       Date:  2012-01-05       Impact factor: 4.430

6.  Familial risks in nervous system tumours: joint Nordic study.

Authors:  K Hemminki; S Tretli; J H Olsen; L Tryggvadottir; E Pukkala; J Sundquist; C Granström
Journal:  Br J Cancer       Date:  2010-05-25       Impact factor: 7.640

7.  Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effects.

Authors:  Karlyne M Reilly; Robert G Tuskan; Emily Christy; Dagan A Loisel; Jeremy Ledger; Roderick T Bronson; C Dahlem Smith; Shirley Tsang; David J Munroe; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-19       Impact factor: 11.205

8.  Aggregation of cancer in first-degree relatives of patients with glioma.

Authors:  Michael E Scheurer; Carol J Etzel; Mei Liu; Randa El-Zein; Gladstone E Airewele; Beatrice Malmer; Kenneth D Aldape; Jeffrey S Weinberg; W K Alfred Yung; Melissa L Bondy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11       Impact factor: 4.254

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.